Who owns X4 PHARMACEUTICALS INC COM NEW?
- Ticker: XFOR
- CUSIP Number: 98420x202
Tip: Access positions for across all investors
Analyze quarterly positions in X4 Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of X4 Pharmaceuticals stock
Who bought or sold X4 PHARMACEUTICALS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Morgan Stanley | 9.5M | $39M | 15% | Mar 2026 |
|
| Empery Asset Management | 8.9M | $37M | 0% | Mar 2026 |
|
| FMR | 8.5M | $34M | 100% | Dec 2025 |
|
| Bain Capital Life Sciences Investors | 8.0M | $33M | 0% | Mar 2026 |
|
| Perceptive Advisors | 6.7M | $28M | 7% | Mar 2026 |
|
| Deep Track Capital | 6.3M | $26M | 26% | Mar 2026 |
|
| Saturn V Capital Management | 5.8M | $23M | 100% | Dec 2025 |
|
| Kalehua Capital Management | 3.7M | $15M | 100% | Mar 2026 |
|
| Vanguard Capital Management | 3.5M | $14M | 100% | Mar 2026 |
|
| Vanguard Group | 3.4M | $14M | 734% | Dec 2025 |
|
| Braidwell | 3.3M | $14M | -3% | Mar 2026 |
|
| Blackstone Group | 2.7M | $11M | 0% | Mar 2026 |
|
| Rosalind Advisors | 2.6M | $10M | 69% | Dec 2025 |
|
| Trails Edge Capital Partners | 2.6M | $11M | 100% | Mar 2026 |
|
| Nantahala Capital Management | 2.4M | $10M | 0% | Mar 2026 |
|
| BVF | 2.2M | $9.2M | 0% | Mar 2026 |
|
| Samsara BioCapital | 1.8M | $7.6M | -7% | Mar 2026 |
|
| Siren | 1.5M | $6.0M | 100% | Dec 2025 |
|
| BlackRock | 1.2M | $5.0M | -1% | Mar 2026 |
|
| Millennium Management | 1.2M | $5.0M | 2062% | Mar 2026 |
|
| Woodline Partners | 1.0M | $4.1M | 0% | Mar 2026 |
|
| Geode Capital Management | 940k | $3.9M | 0% | Mar 2026 |
|
| Goldman Sachs Group | 882k | $3.6M | 6% | Mar 2026 |
|
| Stempoint Capital | 851k | $3.5M | -5% | Mar 2026 |
|
| Stonepine Capital Management | 594k | $2.4M | -44% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 481k | $2.0M | 100% | Mar 2026 |
|
| Silverarc Capital Management | 357k | $1.4M | 100% | Dec 2025 |
|
| VR Adviser | 331k | $1.4M | 100% | Mar 2026 |
|
| UBS Group | 267k | $1.1M | 6375% | Mar 2026 |
|
| State Street Corporation | 198k | $793k | 412% | Dec 2025 |
|
| Northern Trust | 178k | $713k | 100% | Dec 2025 |
|
| Pale Fire Capital SE | 168k | $670k | -7% | Dec 2025 |
|
| Bank of America Corporation | 151k | $622k | 100% | Mar 2026 |
|
| Susquehanna International | 150k | $600k | 17% | Dec 2025 |
|
| Affinity Asset Advisors | 145k | $580k | 100% | Dec 2025 |
|
| Palumbo Wealth Management | 131k | $541k | 16% | Mar 2026 |
|
| Brevan Howard Capital Management | 127k | $526k | 100% | Mar 2026 |
|
| Marshall Wace | 81k | $322k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 68k | $271k | 100% | Dec 2025 |
|
| Charles Schwab Investment Management | 67k | $267k | 100% | Dec 2025 |
|
| Barclays | 58k | $230k | 100% | Dec 2025 |
|
| OMERS Administration Corporation | 57k | $237k | -48% | Mar 2026 |
|
| Hudson Bay Capital Management | 50k | $208k | 56% | Mar 2026 |
|
| Catalyst Funds Management Pty | 47k | $196k | 100% | Mar 2026 |
|
| Susquehanna Portfolio Strategies | 43k | $173k | 100% | Dec 2025 |
|
| Jane Street | 37k | $153k | -59% | Mar 2026 |
|
| Dynamic Technology Lab Private | 36k | $385k | 100% | Mar 2026 |
|
| Citigroup | 36k | $148k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 33k | $136k | 100% | Mar 2026 |
|
| Diametric Capital | 29k | $120k | 100% | Mar 2026 |
|
| Virtu Financial | 23k | $90k | 100% | Dec 2025 |
|
| Lighthouse Investment Partners | 22k | $89k | 100% | Dec 2025 |
|
| Stifel Financial | 22k | $90k | 6% | Mar 2026 |
|
| Invesco | 20k | $83k | 100% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 20k | $81k | 100% | Mar 2026 |
|
| Leucadia National Corporation | 20k | $80k | -25% | Mar 2026 |
|
| Caxton | 16k | $64k | 0% | Mar 2026 |
|
| Two Sigma Investments | 14k | $57k | -20% | Mar 2026 |
|
| Creative Planning | 14k | $57k | -16% | Mar 2026 |
|
| JustInvest | 12k | $48k | 100% | Mar 2026 |
|
| SummitTX Capital | 11k | $46k | 100% | Mar 2026 |
|
| Winton Capital | 11k | $44k | 100% | Mar 2026 |
|
| Tower Research Capital | 10k | $42k | -2% | Dec 2025 |
|
| Indivisible Partners | 10k | $37k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 4.8k | $20k | 831% | Mar 2026 |
|
| Atlantic Trust | 2.2k | $8.7k | 0% | Dec 2025 |
|
| Signature | 2.0k | $8.2k | -28% | Mar 2026 |
|
| Pnc Financial Services | 1.8k | $7.3k | 0% | Mar 2026 |
|
| State of Wyoming | 1.1k | $4.4k | 100% | Mar 2026 |
|
| Acadian Asset Management | 802.00 | $3.0k | 100% | Mar 2026 |
|
| Russell Investments | 729.00 | $3.0k | 0% | Mar 2026 |
|
| Hanson McClain Advisors | 715.00 | $2.9k | 100% | Dec 2025 |
|
| Group One Trading | 712.00 | $2.9k | -82% | Mar 2026 |
|
| Bleichroeder | 595.00 | $2.4k | 0% | Dec 2025 |
|
| Farther Finance Advisors | 331.00 | $1.4k | 0% | Mar 2026 |
|
| Ronald Blue Trust | 284.00 | $1.2k | 0% | Mar 2026 |
|
| Quadrant Capital | 128.00 | $528.998400 | 100% | Mar 2026 |
|
| Parallel Advisors | 116.00 | $478.998800 | 100% | Mar 2026 |
|
| Royal Bank of Canada | 115.00 | $0 | -95% | Mar 2026 |
|
| SBI Securities | 54.00 | $222.998400 | 8% | Mar 2026 |
|
| Jones Financial Companies, L.L | 38.00 | $152.000000 | 0% | Dec 2025 |
|
| Rockefeller Capital Management | 33.00 | $135.999600 | 0% | Mar 2026 |
|
| HighMark Wealth Management | 6.00 | $24.000000 | 0% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 5.00 | $21.000000 | 0% | Mar 2026 |
|
Who sold out of X4 Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Point72 Asset Management | Dec 2025 | 808k | $3.2M |
| Citadel Advisors | Dec 2025 | 129k | $515k |
| ExodusPoint Capital Management | Dec 2025 | 79k | $316k |
| Balyasny Asset Management | Dec 2025 | 65k | $258k |
| Man Group | Dec 2025 | 24k | $97k |
| Renaissance Technologies | Sep 2025 | 19k | $66k |
| Squarepoint Ops | Dec 2025 | 13k | $50k |
| Fortitude Family Office | Dec 2025 | 137.00 | $548.000000 |
| Goss Wealth Management | Dec 2025 | 33.00 | $132.000000 |
| Jpmorgan Chase & Co | Sep 2025 | 33.00 | $112.998600 |